APA (7th ed.) Citation

Cortes-Mejía, N., Guerra-Londono, J. J., Feng, L., Gloria-Escobar, J. M., Lillemoe, H. A., Ovsak, G., & Cata, J. P. (2025). The impact of sugammadex versus neostigmine reversal on return to intended oncological therapy-related outcomes after breast cancer surgery: A retrospective cohort study. Perioperative Medicine, 14(1), 1. https://doi.org/10.1186/s13741-025-00591-z

Chicago Style (17th ed.) Citation

Cortes-Mejía, Nicolas, Juan Jose Guerra-Londono, Lei Feng, Jose Miguel Gloria-Escobar, Heather A. Lillemoe, Gavin Ovsak, and Juan P. Cata. "The Impact of Sugammadex Versus Neostigmine Reversal on Return to Intended Oncological Therapy-related Outcomes After Breast Cancer Surgery: A Retrospective Cohort Study." Perioperative Medicine 14, no. 1 (2025): 1. https://doi.org/10.1186/s13741-025-00591-z.

MLA (9th ed.) Citation

Cortes-Mejía, Nicolas, et al. "The Impact of Sugammadex Versus Neostigmine Reversal on Return to Intended Oncological Therapy-related Outcomes After Breast Cancer Surgery: A Retrospective Cohort Study." Perioperative Medicine, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s13741-025-00591-z.